Annals of Surgical Oncology

, Volume 24, Issue 5, pp 1188–1194 | Cite as

Intraperitoneal Administration of Plasma-Activated Medium: Proposal of a Novel Treatment Option for Peritoneal Metastasis From Gastric Cancer

  • Shigeomi Takeda
  • Suguru YamadaEmail author
  • Norifumi Hattori
  • Kae Nakamura
  • Hiromasa Tanaka
  • Hiroaki Kajiyama
  • Mitsuro Kanda
  • Daisuke Kobayashi
  • Chie Tanaka
  • Tsutomu Fujii
  • Michitaka Fujiwara
  • Masaaki Mizuno
  • Masaru Hori
  • Yasuhiro Kodera
Gastrointestinal Oncology



The administration of fluid irradiated with non-equilibrium atmospheric pressure plasma (NEAPP) has attracted much interest as a novel therapeutic method for cancer. The authors previously reported on the efficacy of plasma-activated medium (PAM) for treating cancer cell lines through the induction of apoptosis. In this study, the therapeutic effect of PAM was evaluated in vivo using a peritoneal metastasis mouse model.


Two gastric cancer cell lines were used in proliferation assays performed to optimize the production of PAM by changing the distance between the plasma source and the medium surface and by altering the volume of irradiated medium. Wound-healing and adhesion assays were conducted to determine the effect of PAM therapy on cell migration and adhesion capacity in vitro. Finally, a mouse model established by the intraperitoneal injection of enhanced green fluorescent protein-tagged gastric cancer cells was used to explore the efficacy of PAM administered intraperitoneally in inhibiting peritoneal metastasis formation.


Shorter distances between the plasma source and the medium surface and smaller volumes of treated medium increased the anti-tumor effect of PAM. The PAM treatment attenuated gastric cancer cell migration and adhesion in vitro. The intraperitoneal administration of PAM decreased the formation of peritoneal metastatic nodules by 60% in the mouse model, and no adverse events were observed.


Plasma-activated liquids may represent a novel therapeutic method for the treatment of peritoneal metastases in gastric cancer.


Gastric Cancer Cell Peritoneal Metastasis Intraperitoneal Administration Peritoneal Dissemination Adhesion Capacity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



There are no conflict of interest.

Supplementary material

10434_2016_5759_MOESM1_ESM.ppt (848 kb)
Supplementary material 1 (PPT 845 kb) Experimental system for producing PAM. (a) Photograph of our device. (b) Schematics of PAM production.
10434_2016_5759_MOESM2_ESM.pptx (74 kb)
Supplementary material 2 (PPTX 73 kb)Effect of repeated PAM exposure. A total of 3×103 cells were seeded into a 96-well plate, and the medium was replaced as follows. Untreated: The medium was replaced every 24 h with RPMI-1640. 1: At 24 h after seeding, the medium was replaced with PAM, and after another 24 h and 48 h, the medium was replaced with RPMI-1640. 2: At 24 h and 48 h after seeding, the medium was replaced with PAM, and after another 24 h, the medium was replaced with RPMI-1640. 3: At 24 h, 48 h and 72 h after seeding, the medium was replaced with PAM. Finally, at 96 h after seeding, an MTS assay was performed, and the proliferation rates were calculated. Each column represents the mean of three replicates, and the error bars represent standard deviation.


  1. 1.
    Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat. 2014;46:109–23.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRefPubMedGoogle Scholar
  3. 3.
    Shiozaki H, Elimova E, Slack RS, et al. Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases. J Surg Oncol. 2015;113:29–35.CrossRefPubMedGoogle Scholar
  4. 4.
    Brun P, Brun P, Vono M, et al. Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma. PLoS One. 2012;7:e33245.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Fridman G, Friedman G, Gutsol A, Shekhter AB, Vasilets VN, Fridman A. Applied plasma medicine. Plasma Process Polym. 2008;5:503–33.CrossRefGoogle Scholar
  6. 6.
    Fridman G, Peddinghaus M, Balasubramanian M, Ayan H, Fridman A, Gutsol A, et al. Blood coagulation and living tissue sterilization by floating-electrode dielectric barrier discharge in air. Plasma Chem Plasma Proc. 2006;26:425–42.CrossRefGoogle Scholar
  7. 7.
    Ahn HJ, Kim KI, Kim G, Moon E, Yang SS, Lee JS. Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals. PLoS One. 2011;6:e28154.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Gesbert F, Larue L. Non-thermal plasmas: novel preventive and curative therapy against melanomas? Exp Dermatol. 2014;23:716–7.CrossRefPubMedGoogle Scholar
  9. 9.
    Hou J, Ma J, Yu KN, Li W, Cheng C, Bao L, Han W. Nonthermal plasma treatment altered gene expression profiling in non-small cell lung cancer A549 cells. BMC Genomics. 2015;16:435.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Ma Y, Ha CS, Hwang SW, Lee HJ, Kim GC, Lee KW, Song K. Nonthermal atmospheric pressure plasma preferentially induces apoptosis in p53-mutated cancer cells by activating ROS stress-response pathways. PLoS One. 2014;9:e91947.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Thiyagarajan M, Sarani A, Gonzales XF. Characterization of an atmospheric pressure plasma jet and its applications for disinfection and cancer treatment. Stud Health Technol Inform. 2013;184:443–9.PubMedGoogle Scholar
  12. 12.
    Tanaka H, Mizuno M, Ishikawa K, et al. Plasma with high electron density and plasma-activated medium for cancer treatment. Clin Plasma Med. 2015;3:72–6.CrossRefGoogle Scholar
  13. 13.
    Tanaka H, Mizuno M, Toyokuni S, et al. Cancer therapy using nonthermal atmospheric pressure plasma with ultra-high electron density. Phys Plasmas. 2015;22:122004.CrossRefGoogle Scholar
  14. 14.
    Tanaka H, Mizuno M, Ishikawa K, et al. Plasma-activated medium selectively kills glioblastoma brain tumor cells by downregulating a survival signaling molecule, AKT kinase. Plasma Med. 2011;1:265–77.CrossRefGoogle Scholar
  15. 15.
    Hattori N, Yamada S, Torii K, et al. Effectiveness of plasma treatment on pancreatic cancer cells. Int J Oncol. 2015;47:1655–62.PubMedPubMedCentralGoogle Scholar
  16. 16.
    Torii K, Yamada S, Nakamura K, et al. Effectiveness of plasma treatment on gastric cancer cells. Gastric Cancer. 2014;18:635–43.CrossRefPubMedGoogle Scholar
  17. 17.
    Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Hori M, Kikkawa F. Selective cytotoxicity of indirect nonequilibrium atmospheric pressure plasma against ovarian clear-cell carcinoma. Springerplus. 2014;3:398.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chang JW, Kang SU, Shin YS, et al. Non-thermal atmospheric pressure plasma inhibits thyroid papillary cancer cell invasion via cytoskeletal modulation, altered MMP-2/-9/uPA activity. PLoS One. 2014;9:e92198.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kim CH, Kwon S, Bahn JH, Lee K, Jun SI, Rack PD, Baek SJ. Effects of atmospheric nonthermal plasma on invasion of colorectal cancer cells. Appl Phys Lett. 2010;96:243701.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Utsumi F, Kajiyama H, Nakamura K, et al. Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PLoS One. 2013;8:e81576.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ohashi N, Kodera Y, Nakanishi H, et al. Efficacy of intraperitoneal chemotherapy with paclitaxel targeting peritoneal micrometastasis as revealed by GFP-tagged human gastric cancer cell lines in nude mice. Int J Oncol. 2005;27:637–44.PubMedGoogle Scholar
  22. 22.
    Kieft IE, Broers JLV, Caubet-Hilloutou V, Slaaf DW, Ramaekers FCS, Stoffels E. Electric discharge plasmas influence attachment of cultured CHO K1 cells. Bioelectromagnetics. 2004;25:362–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Keidar M, Walk R, Shashurin A, et al. Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer. 2011;105:1295–301.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Vandamme M, Robert E, Dozias S, Sobilo J, Lerondel S, Le Pape A, et al. Response of human glioma U87 xenografted on mice to nonthermal plasma treatment. Plasma Med. 2011;1:27–43.CrossRefGoogle Scholar
  25. 25.
    Brulle L, Vandamme M, Ries D, et al. Effects of a nonthermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PLoS One. 2012;7:e52653.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Vandamme M, Robert E, Lerondel S, et al. ROS implication in a new antitumor strategy based on nonthermal plasma. Int J Cancer. 2012;130:2185–94.CrossRefPubMedGoogle Scholar
  27. 27.
    Walk RM, Snyder JA, Srinivasan P, et al. Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg. 2013;48:67–73.CrossRefPubMedGoogle Scholar
  28. 28.
    Utsumi F, Kajiyama H, Nakamura KAE, et al. Variable susceptibility of ovarian cancer cells to nonthermal plasma-activated medium. Oncol Rep. 2016;35:3169–77.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Joh HM, Choi JY, Kim SJ, Chung TH, Kang TH. Effect of additive oxygen gas on cellular response of lung cancer cells induced by atmospheric-pressure helium plasma jet. Sci Rep. 2014;4:6638.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Winter J, Wende K, Masur K, et al. Feed gas humidity: a vital parameter affecting a cold atmospheric-pressure plasma jet and plasma-treated human skin cells. J Phys D Appl Phys. 2013;46:295401.CrossRefGoogle Scholar
  31. 31.
    Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt. 2001;6:432–40.CrossRefPubMedGoogle Scholar
  32. 32.
    Kishimoto H, Zhao M, Hayashi K, et al. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. Proc Natl Acad Sci USA. 2009;106:14514–7.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Kishimoto H, Aki R, Urata Y, et al. Tumor-selective, adenoviral-mediated GFP genetic labeling of human cancer in the live mouse reports future recurrence after resection. Cell Cycle. 2011;10:2737–41.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol. 2001;19:316–7.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2017

Authors and Affiliations

  • Shigeomi Takeda
    • 1
  • Suguru Yamada
    • 1
    Email author
  • Norifumi Hattori
    • 1
  • Kae Nakamura
    • 2
  • Hiromasa Tanaka
    • 3
  • Hiroaki Kajiyama
    • 2
  • Mitsuro Kanda
    • 1
  • Daisuke Kobayashi
    • 1
  • Chie Tanaka
    • 1
  • Tsutomu Fujii
    • 1
  • Michitaka Fujiwara
    • 1
  • Masaaki Mizuno
    • 4
  • Masaru Hori
    • 3
  • Yasuhiro Kodera
    • 1
  1. 1.Department of Gastroenterological Surgery (Surgery II)Nagoya University Graduate School of MedicineNagoyaJapan
  2. 2.Department of Obstetrics and GynecologyNagoya University Graduate School of MedicineNagoyaJapan
  3. 3.Institutes of Innovation for Future SocietyNagoya UniversityNagoyaJapan
  4. 4.Center for Advanced Medicine and Clinical ResearchNagoya University Graduate School of MedicineNagoyaJapan

Personalised recommendations